GlobeNewswire 2019-12-08 Karyopharm Presents XPOVIO® (Selinexor) and Eltanexor Data at the American Society of Hematology 201...
GlobeNewswire 2019-12-06 Data from Investigator-Sponsored Phase 2 Study of Calithera’s Telaglenastat with Azacitidine in Myel...
GlobeNewswire 2019-08-02 Laurie L. Harris Joins Synchronoss Technologies Board of Directors
GlobeNewswire 2019-07-16 Paper Co-Authored by BigLever to Spotlight Feature-Based Product Line Engineering at INCOSE Internat...
GlobeNewswire 2019-05-02 Evine Secures Multi-Million Dollar Strategic Investment & Exclusivity Commitment from The Invicta Wa...
GlobeNewswire 2019-01-30 Global Palm Oil (Food & industrial) Market Analysis, Trends, and Forecasts, 2016-2019 & 2024
GlobeNewswire 2019-01-02 Onconova Submits Special Protocol Assessment (SPA) to FDA for Phase 3 Trial of Oral Rigosertib in Co...
TeleTrader 2018-08-06 Europe ends mostly lower, focus on trade concerns, Iran sanctions
GlobeNewswire 2018-07-02 MEDIA ADVISORY: BigLever CEO Spotlights Latest Advances in Product Line Engineering for the Enterpri...
GlobeNewswire 2018-07-02 Entra ASA : Signed new lease contracts
GlobeNewswire 2018-06-15 TG Therapeutics, Inc. Announces Oral Presentation of Umbralisib plus Ruxolitinib in Patients with My...
GlobeNewswire 2018-03-26 Onconova Presents Promising Data from Phase 2 Expansion Study of Oral Rigosertib and Azacitidine Com...
GlobeNewswire 2018-01-23 Palm Oil Markets 2016-2024: Food Applications & Industrial Applications - Global Strategic Business ...
GlobeNewswire 2017-09-20 Novartis drug Rydapt® (midostaurin) receives EU approval for newly diagnosed FLT3-mutated acute myel...
GlobeNewswire 2017-07-21 Novartis receives positive CHMP opinion for Rydapt® (midostaurin) for newly diagnosed FLT3-mutated a...
GlobeNewswire 2017-06-05 Onconova Therapeutics Announces Positive Phase 2 Data in Rigosertib Treated Patients with Second-lin...
GlobeNewswire 2017-06-02 STMicroelectronics and ZTE Team to Promote LoRa Technology and Applications in China
GlobeNewswire 2017-04-28 Novartis receives FDA approval for Rydapt® in newly diagnosed FLT3-mutated acute myeloid leukemia (A...
GlobeNewswire 2017-03-27 Onconova Therapeutics, Inc. Reports Recent Business Highlights and Year-end 2016 Financial Results
GlobeNewswire 2016-12-05 Onconova Presents Phase 2 Data from Oral Rigosertib and Azacitidine Combination Trial in Higher-Risk...
GlobeNewswire 2016-11-29 Cellular Biomedicine Group (CBMG) Approved to Commence Phase I Trial (CARD-1) for C-CAR011 in Patien...
GlobeNewswire 2011-03-15 Second Phase III study of Novartis JAK inhibitor INC424 meets primary endpoint in patients with myel...
GlobeNewswire 2010-12-20 Novartis investigational JAK inhibitor INC424 data met primary endpoint in Phase III trial of patien...
GlobeNewswire 2010-12-01 Data at ASH, SABCS demonstrate commitment of Novartis R&D in advancing treatments for patients with ...